Laboratorios Farmaceuticos Rovi SA (fra:41L) Share Price

Company Profile

Business description
Laboratorios Farmaceuticos Rovi SA is a biotechnology company engaged in the research, development, manufacturing, and marketing of small molecule and specialty biologic drugs. The company has a diversified portfolio of products that it markets in Spain through its specialized sales force of specialist physicians, hospitals and pharmacies. Laboratorios' research and development pipeline is focused on the expansion of applications, indications, and alternative mechanisms of action for heparin-derived products. The company aims to obtain new pharmaceutical products that enable the regular administration of formulations that are administered daily in chronic and prolonged treatments. Its two segments are Manufacturing and Marketing.
Contact
Julian Camarillo, 35
Madrid28037
ESP
T: +34 913756230
E: [email protected]
https://www.rovi.es
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2025
Employees
2,188

Recommended

Does recent share price weakness spell opportunity in these three high-quality companies? Our analysts think so.

Joseph Taylor | 11 September 2025

The media group has excelled in controlling what it can control. Now the focus shifts to capital deployment.

Brian Han | 11 September 2025

Shares jumped in response to the latest results.

Luke Yang, CFA | 11 September 2025

Index	Last price	Change	% Change
All Ordinaries	9,128.70	18.10	0.20%
CAC 40	7,825.24	1.72	0.02%
DAX 40	23,698.15	5.50	-0.02%
Dow JONES (US)	45,834.22	273.78	-0.59%
FTSE 100	9,283.29	14.29	-0.15%
HKSE	26,388.16	301.84	1.16%
NASDAQ	22,141.10	98.03	0.44%
Nikkei 225	44,768.12	395.62	0.89%
NZX 50 Index	13,227.90	1.25	-0.01%
S&P 500	6,584.29	3.18	-0.05%
S&P/ASX 200	8,864.90	22.00	0.25%
SSE Composite Index	3,870.60	4.71	-0.12%